DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Zuckerman E, Gutierrez JA, Dylla DE. et al.
Eight Weeks Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naive Patients With Hepatitis C Virus Infection.
Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 2020;
DOI: 10.1016/j.cgh.2020.06.044.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.